Thrombosis Pipeline Review, H2 2015 - Research and Markets

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/5bzpq8/thrombosis) has announced the addition of the "Thrombosis - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Thrombosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Thrombosis and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Thrombosis Overview
  3. Therapeutics Development
  4. Pipeline Products for Thrombosis - Overview
  5. Pipeline Products for Thrombosis - Comparative Analysis
  6. Thrombosis - Therapeutics under Development by Companies
  7. Thrombosis - Therapeutics under Investigation by Universities/Institutes
  8. Thrombosis - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Thrombosis - Products under Development by Companies
  13. Thrombosis - Products under Investigation by Universities/Institutes
  14. Thrombosis - Companies Involved in Therapeutics Development
  • 3SBio Inc.
  • Antibe Therapeutics, Inc.
  • Archemix Corp.
  • Arena Pharmaceuticals, Inc.
  • Armetheon, Inc.
  • Arrowhead Research Corporation
  • Astellas Pharma Inc.
  • AstraZeneca Plc
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Cardax Pharmaceuticals, Inc.
  • Cereno Scientific AB
  • China Biologic Products, Inc.
  • Daewoong Pharmaceutical Co., Ltd.
  • Daiichi Sankyo Company, Limited
  • Dyax Corp.
  • Eisai Co., Ltd.
  • F. Hoffmann-La Roche Ltd.
  • GlycoMimetics, Inc.
  • Green Cross Corporation
  • Johnson & Johnson
  • Laboratorios Farmaceuticos Rovi, S.A.
  • LG Life Science LTD.
  • Lipicard Technologies Limited
  • Merrion Pharmaceuticals Plc
  • Pfizer Inc.
  • PLx Pharma Inc.
  • Portola Pharmaceuticals, Inc.
  • Prothix BV
  • Sagene Pharmaceuticals, Inc.
  • Sanofi
  • SciFluor Life Sciences, LLC
  • The International Biotechnology Center (IBC) Generium
  • Zedira GmbH
  • Zydus Cadila Healthcare Limited

For more information visit http://www.researchandmarkets.com/research/5bzpq8/thrombosis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular